Cybin (CYBN) Competitors

Immatics (NASDAQ:IMTX) and Cybin (NYSE:CYBN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.

Does the MarketBeat Community believe in IMTX or CYBN?

Immatics received 15 more outperform votes than Cybin when rated by MarketBeat users. However, 100.00% of users gave Cybin an outperform vote while only 75.61% of users gave Immatics an outperform vote.

Company	Underperform	Outperform
Immatics	Outperform Votes 31 75.61%	Underperform Votes 10 24.39%
Cybin	Outperform Votes 16 100.00%	Underperform Votes No Votes

Does the media refer more to IMTX or CYBN?

In the previous week, Immatics had 3 more articles in the media than Cybin. MarketBeat recorded 3 mentions for Immatics and 0 mentions for Cybin. Immatics' average media sentiment score of 1.33 beat Cybin's score of 0.00 indicating that Immatics is being referred to more favorably in the media.

Company	Overall Sentiment
Immatics	Positive
Cybin	Neutral

Which has preferable valuation and earnings, IMTX or CYBN?

Cybin has lower revenue, but higher earnings than Immatics. Cybin is trading at a lower price-to-earnings ratio than Immatics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Immatics	$155.84M	3.41	-$104.98M	$0.14	31.21
Cybin	N/A	N/A	-$57.88M	-$4.38	-1.76

Do analysts prefer IMTX or CYBN?

Immatics currently has a consensus target price of $16.67, suggesting a potential upside of 281.39%. Cybin has a consensus target price of $86.00, suggesting a potential upside of 1,016.88%. Given Cybin's higher possible upside, analysts plainly believe Cybin is more favorable than Immatics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Immatics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
Cybin	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is IMTX or CYBN more profitable?

Cybin has a net margin of 0.00% compared to Immatics' net margin of -47.94%. Immatics' return on equity of -15.90% beat Cybin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Immatics	-47.94%	-15.90%	-9.38%
Cybin	N/A	-37.58%	-36.59%

Do institutionals and insiders hold more shares of IMTX or CYBN?

64.4% of Immatics shares are owned by institutional investors. Comparatively, 17.9% of Cybin shares are owned by institutional investors. 3.3% of Immatics shares are owned by insiders. Comparatively, 15.0% of Cybin shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more risk & volatility, IMTX or CYBN?

Immatics has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, Cybin has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500.

Summary

Immatics beats Cybin on 11 of the 17 factors compared between the two stocks.